Clin2
NCT07631364Possibly a fitNot yet recruiting

Temocillin for gonorrhea without symptoms

Neisseria Gonorrhoeae (Ng) Infections

Treatments studied

Part of Infections clinical trials.

This study compares a new antibiotic (temocillin) to the standard treatment for gonorrhea that is not causing symptoms. It aims to see if temocillin works as well or better, and you may get either treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
360 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older
  • You have tested positive for gonorrhea but have no symptoms
  • You are not allergic to penicillin or similar antibiotics
  • You do not have serious heart, kidney, or liver disease, or a bleeding disorder
  • You are not currently taking other antibiotics (except doxycycline for prevention)
  • You can speak French, English, or Spanish

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07070102Not yet recruiting
Temocillin dosing study for kidney infections in children

This study looks at how the antibiotic temocillin works in children with kidney infections (pyelonephritis). It helps find the right dose to treat the infection safely and effectively, but only for kids who need hospital care.

Paris, Ap-hp / DRCI
NCT07675018Not yet recruiting
Using a test result to guide antibiotic choice for urinary infections

This trial tests whether a specific urine test result can help doctors safely avoid using strong, broad-spectrum antibiotics in patients with urinary tract infections. It aims to reduce unnecessary antibiotic use while still treating the infection effectively.

Chambray-lès-Tours
NCT07710118Recruiting· Phase 3
Comparing two doses of ceftriaxone for gonorrhea in men

This trial is testing whether a lower dose (500 mg) of the antibiotic ceftriaxone works as well as the standard dose (1000 mg) for treating gonorrhea in men. If you have a gonorrhea infection in your throat, rectum, or genitals and are otherwise healthy, you may be able to join.

Taipei
NCT07758972Recruiting· Phase 1
Gonorrhea vaccine safety study

This trial tests a new vaccine designed to protect against gonorrhea, a common sexually transmitted infection. The study checks how safe the vaccine is and how well it trains the immune system to fight the bacteria.

Neu-Ulm, Bavaria
NCT07569900Recruiting
Testing a new gonorrhea test for women

This study evaluates a new rapid test for gonorrhea designed for women. You'll provide vaginal swab samples and complete a brief counseling session to help researchers understand how well the test works and whether patients can use it correctly.

Johannesburg, Gauteng
NCT05286931Recruiting
Test for gonorrhea using a urine swab lab assay

This study checks whether a specific lab test (the “gyrA assay”) can detect gonorrhea in people who do not have symptoms. It may help clinicians find gonorrhea more quickly and with the right treatment when symptoms aren’t present.

Seattle, Washington

Hear when a new Neisseria Gonorrhoeae (Ng) Infections trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.